February 9, 2023 Blood was drawn from 16 breast cancer patients and enriched for Circulating Tumor Cells (CTCs) using LiquidScan. Isolated cells were analyzed for HER2 positivity [Read More...]
HER2+ Breast Cancer Pilot Studykari2023-02-09T17:50:30-08:00